Background: Open prostatectomy for the surgical management of benign prostate hyperplasia (BPH) is now rarely used in most developed countries except for large prostates. However, in resource limited coun­tries, open prostatectomy remains the main mode of surgical management of benign prostate hyperplasia irrespective of the prostate size. Surgical treatment is reserved for refractory cases, as well as cases involving recurrent urinary retention, recurrent urinary tract in­fection, recurrent hematuria, bladder calculi or upper urinary tract involvement. The study highlights the surgical management of BPH using open simple pros­tatectomy with emphasis on indication and outcome.

Methods: This is a 5-year retrospective descriptive study performed at the 2 Referral Hospitals from 2018 to 2023.

Results: 60 patients were reviewed following simple prostatectomy. The age range was 55 years to 78 years with a mean age was 65.1 years. The mean preopera­tive hemoglobin was 11.6 g/dl. The age range was 55 years to 78 years with a mean age was 65.1 years. The mean preoperative hemoglobin was 11.6 g/dl. The perioperative transfusion rate was 27/60 (45%). BPH and Chronic urinary retention was the commonest indication for surgery which was 16/60 (26.6%) of all cases. About 45/60 (75.0%) of the procedures were performed through the transvesical approach. Sys­temic hypertension 31/60 (51.7%) was the common­est comorbidity. The data showed a strong correlation between patients with indwelling catheter before sur­gery and surgical site infection 9/13 (69.2%).

Conclusion: In the absence of endourological proce­dures, simple prostatectomy is broadly performed for all sizes of prostate. The postoperative morbidity is high, but the outcome is acceptable.